113 related articles for article (PubMed ID: 22025256)
1. Use of fetal nuchal translucency in the first trimester to predict single-gene disorders.
Arigita M; Borrell A; Mula R; Sanchez A; Milà M; Gratacos E
Prenat Diagn; 2011 Dec; 31(12):1164-8. PubMed ID: 22025256
[TBL] [Abstract][Full Text] [Related]
2. Nuchal translucency thickness in the prediction of unbalanced translocations.
Arigita M; Grande M; Mula R; Borobio V; Sanchez A; Soler A; Borrell A
Prenat Diagn; 2014 Oct; 34(10):982-5. PubMed ID: 24863889
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
Yang Y; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
[TBL] [Abstract][Full Text] [Related]
4. Male gender as a favorable prognostic factor in pregnancies with enlarged nuchal translucency.
Timmerman E; Pajkrt E; Bilardo CM
Ultrasound Obstet Gynecol; 2009 Oct; 34(4):373-8. PubMed ID: 19618399
[TBL] [Abstract][Full Text] [Related]
5. [Increased nuchal translucency at 11-14 weeks of gestation in congenital heart disease, genetic syndromes and adverse pregnancy outcome].
Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Loquet P
Akush Ginekol (Sofiia); 2005; 44(6):8-15. PubMed ID: 18982826
[TBL] [Abstract][Full Text] [Related]
6. Nuchal translucency in fetuses affected by homozygous alpha-thalassemia-1 at 12-13 weeks of gestation.
Lam YH; Tang MH; Lee CP; Tse HY
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):238-40. PubMed ID: 10341400
[TBL] [Abstract][Full Text] [Related]
7. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency.
Martínez JM; Comas M; Borrell A; Bennasar M; Gómez O; Puerto B; Gratacós E
Ultrasound Obstet Gynecol; 2010 Mar; 35(3):267-72. PubMed ID: 20052662
[TBL] [Abstract][Full Text] [Related]
8. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
[TBL] [Abstract][Full Text] [Related]
9. Comparison of likelihood ratios of first-trimester nuchal translucency measurements: multiples of median, delta or mixture.
Sahota DS; Leung TY; Chen M; Chan LW; Fung TY; Lau TK
Ultrasound Obstet Gynecol; 2010 Jul; 36(1):15-9. PubMed ID: 20503228
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester soft markers: relation to first-trimester nuchal translucency in unaffected pregnancies.
Miguelez J; De Lourdes Brizot M; Liao AW; De Carvalho MH; Zugaib M
Ultrasound Obstet Gynecol; 2012 Mar; 39(3):274-8. PubMed ID: 21484908
[TBL] [Abstract][Full Text] [Related]
11. Impact of nuchal cord on measurement of fetal nuchal translucency thickness.
Scheier M; Egle D; Himmel I; Ramoni A; Viertl S; Huter O; Marth C
Ultrasound Obstet Gynecol; 2007 Aug; 30(2):197-200. PubMed ID: 17573675
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
13. Increased nuchal translucency thickness and risk of neurodevelopmental disorders.
Hellmuth SG; Pedersen LH; Miltoft CB; Petersen OB; Kjaergaard S; Ekelund C; Tabor A
Ultrasound Obstet Gynecol; 2017 May; 49(5):592-598. PubMed ID: 27183961
[TBL] [Abstract][Full Text] [Related]
14. Prospective validation of first-trimester combined screening for trisomy 21.
Kagan KO; Etchegaray A; Zhou Y; Wright D; Nicolaides KH
Ultrasound Obstet Gynecol; 2009 Jul; 34(1):14-8. PubMed ID: 19526452
[TBL] [Abstract][Full Text] [Related]
15. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
16. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation.
Molina FS; Avgidou K; Kagan KO; Poggi S; Nicolaides KH
Obstet Gynecol; 2006 Mar; 107(3):678-83. PubMed ID: 16507941
[TBL] [Abstract][Full Text] [Related]
17. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
18. First-trimester fetal nuchal translucency and inherited metabolic disorders.
De Biasio P; Prefumo F; Casagrande V; Stroppiano M; Venturini PL; Filocamo M
Prenat Diagn; 2006 Jan; 26(1):77-80. PubMed ID: 16378318
[TBL] [Abstract][Full Text] [Related]
19. Increased nuchal translucency and normal karyotype: perinatal and pediatric outcomes at 2 years of age.
Mula R; Goncé A; Bennásar M; Arigita M; Meler E; Nadal A; Sánchez A; Botet F; Borrell A
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):34-41. PubMed ID: 21837766
[TBL] [Abstract][Full Text] [Related]
20. [Distribution and normal reference range of fetal nuchal translucency thickness in Kunming pregnant women in the first trimester].
Sun Q; Xu J; Hu SQ; Chen M; Ma RM; Lau TK; Zhang L; Xiao X; Qian Y; Guo Z
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):514-7. PubMed ID: 23141162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
